Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
OVERLAP
                46%
                                OVERLAP
BY WEIGHT
22
                                # OF OVERLAPPING
HOLDINGS
FBCG
                            178
                                HOLDINGS
                            
                                    11%
                                
                                ALSO IN FDG
                            FDG
                            39
                                HOLDINGS
                            
                                    59%
                                
                                ALSO IN FBCG
                            SECTOR DRIFT (FBCG minus FDG)
                OVERLAPPING HOLDINGS
                Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FBCG  | 
                                Weight in FDG  | 
                                Overlap | |
|---|---|---|---|---|
| NVIDIA CORP | 16.0% | 19.1% | 16.0% | |
| AMAZON.COM INC | 9.2% | 10.3% | 9.2% | |
| MICROSOFT CORP | 7.7% | 6.0% | 6.0% | |
| META PLATFORMS INC | 5.2% | 6.8% | 5.2% | |
| NETFLIX INC | 3.4% | 5.2% | 3.4% | |
FBCG Overweight Relative to FDG
                | APPLE INC | 10.3% | |
| ALPHABET INC. CLASS A | 8.9% | |
| ELI LILLY & CO | 2.1% | |
| BROADCOM INC. | 2.0% | |
| MARVELL TECHNOLOGY, INC. | 1.8% | |
| APPLOVIN CORP. CLASS A | 1.8% | |
| MICROSOFT CORP | 1.7% | |
| CARVANA CO. CLASS A | 1.2% | |
| NXP SEMICONDUCTORS NV | 1.0% | |
| TAIWAN SEMICONDUCTOR-SP ADR | 1.0% | 
FBCG Underweight Relative to FDG
                | ALPHABET INC. CLASS C | -7.2% | |
| TESLA MOTORS INC | -5.8% | |
| ALNYLAM PHARMACEUTICALS INC | -4.7% | |
| ROCKET LAB USA, INC. | -4.5% | |
| SALESFORCE.COM INC | -3.3% | |
| NVIDIA CORP | -3.1% | |
| CADENCE DESIGN SYS INC | -2.5% | |
| MASTERCARD INCORPORATED CLASS A | -2.3% | |
| SHOPIFY, INC. CLASS A | -2.2% | |
| ASCENDIS PHARMA A/S | -2.1% |